| Product Code: ETC9948105 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Malaria Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Malaria Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) Malaria Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.6 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 United Kingdom (UK) Malaria Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Malaria Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in the UK due to travel to endemic regions |
4.2.2 Government initiatives and funding for malaria prevention and treatment programs |
4.2.3 Technological advancements in malaria diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Rising drug resistance leading to treatment inefficacy |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
4.3.3 High treatment costs impacting accessibility for patients |
5 United Kingdom (UK) Malaria Treatment Market Trends |
6 United Kingdom (UK) Malaria Treatment Market, By Types |
6.1 United Kingdom (UK) Malaria Treatment Market, By Agent |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Agent, 2021- 2031F |
6.1.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.1.4 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By P. Vivax, 2021- 2031F |
6.1.5 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By P. Ovale, 2021- 2031F |
6.1.6 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By P. Malariae, 2021- 2031F |
6.1.7 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By P. Knowlelsi, 2021- 2031F |
6.2 United Kingdom (UK) Malaria Treatment Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.3 United Kingdom (UK) Malaria Treatment Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Suppressive treatment, 2021- 2031F |
6.3.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Radical treatment, 2021- 2031F |
6.4 United Kingdom (UK) Malaria Treatment Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 United Kingdom (UK) Malaria Treatment Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 United Kingdom (UK) Malaria Treatment Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.6.4 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Home healthcare, 2021- 2031F |
6.7 United Kingdom (UK) Malaria Treatment Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Direct tender, 2021- 2031F |
6.7.3 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.7.4 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
6.7.5 United Kingdom (UK) Malaria Treatment Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 United Kingdom (UK) Malaria Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Malaria Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) Malaria Treatment Market Imports from Major Countries |
8 United Kingdom (UK) Malaria Treatment Market Key Performance Indicators |
8.1 Number of diagnosed malaria cases in the UK |
8.2 Rate of adoption of new malaria treatment technologies |
8.3 Research and development investment in malaria treatment innovations |
8.4 Patient adherence to prescribed malaria treatment regimens |
9 United Kingdom (UK) Malaria Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.2 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United Kingdom (UK) Malaria Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Malaria Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) Malaria Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Malaria Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here